Tag Archives: benchmarking

Competitive Intelligence Guidelines & Policies Keeping Companies in the Safety Zone

Competitive Intelligence (CI) groups are instrumental in helping world-class companies to anticipate and respond strategically to external change. Primary and secondary competitive intelligence research helps organizations to improve their chances for success in today’s competitive business environment. While there are

Developing & Maintaining Strategic Professional & Trade Relations Functions

Professional and trade relations groups are critical for dealing with a company’s critical stakeholder groups, such as professional, payer, and patient organizations. Despite this, these groups still must show value within healthcare organizations, while external trends are constantly shaping the

The First 3 Commandments of Internal Branding

In the last blog post, I promised to bring greater detail to how pharma companies should brand a product internally before reaching out to the public. The first three “commandments” generally occur during Phase II of a planned drug launch, and provide

The First 100 Days: Ensuring Successful Mergers & Acquisitions

It seems like every week that there is an announcement of a new merger or some company in the pharmaceutical or technology industry looking to acquire another company. When these announcements come down, a lot of angst occurs for front-line staff

Google & Apple Announce New Health Care Innovations

When Google and Novartis business unit Alcon announced recently that they would partner to bring a “smart” contact lens to the market, it put an exclamation mark on the next wave in health care innovation. Earlier this year, Apple announced its

Mastering Brand Leadership To Reap Product Success

Last week’s post by Cameron Tew, “Why Great Brand Managers are Even Better Leaders,” was about how the best brand team leaders can elicit loyalty and focus from members who come to the product team from various functional teams. Ultimately,

Effectively & Efficiently Serving Thought Leaders

As this slide shows, Medical Affairs, Clinical Affairs and Marketing all have a hand in the management of Key Opinion Leaders (KOLs). Unfortunately, these functions are seldom bridged by processes, personnel or systems. When such work silos are created, you can be

SPECIAL: Highlights from 2014-2015 Digital Marketing Consortium 1st Roundtable

Best Practices, LLC recently held the first Roundtable for the 2014-2015 Digital Marketing Consortium. The virtual conference brought together digital marketing leaders from the pharmaceutical, medical device and biotech industries. The Roundtable, titled “Digital Marketing Service Delivery & Execution Excellence,”

Why Great Brand Managers are Even Better Leaders

Companies frequently search for ways to gauge success and often come up with practical measures to decide whether a product is a boon or a bust. Executives often believe that by setting measurable goals that brand teams can create a

Best Practices Kicks off 2014-2015 Medical Affairs Consortium

Medical Affairs functions have a significant influence on a healthcare company’s overall success. As the pharmaceutical, biotech, medical device, and health care technology markets become increasingly competitive and complex, it is crucial for leaders to understand how to best operate

Effective Thought Leader Engagement: Winning Support Vs. Earning Trust

For many years, my company has been asked by pharmaceutical and medical device companies how to best win the support of industry thought-leaders. As the health care environment has grown more complex and scrutinized, I no longer believe companies should

Success Factors & Lessons Learned in New Product Launches

In today’s competitive & crowded marketplace, biopharmaceutical companies are investing more and more resources to develop and launch new products for cardiovascular therapeutic areas. Consequently, recent industry product launches have produced both noteworthy failures and successes. It is now, more

Best Practices in Innovative Payer Market Research

The overall influence of payers is rising and the types of payers influencing healthcare access are diversifying in today’s rapidly changing healthcare marketplace. Understanding how to navigate this difficult payer landscape is essential for any company hoping to compete and

Optimizing Government Affairs & Public Policy Groups’ Structures & Operations

Public Policy and Government Affairs functions within the pharmaceutical industry have become increasingly critical during this period of political, economic, and social turbulence. With both functions involved in essential areas such as legislative affairs, reimbursement, and regulatory, it’s important for